2DM-26045-98426
3 vaccinations
2 coded responses
28 check-ins
2 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 36-40
- ZIP prefix
- 236 / VA
- Registered
- 2021-03-10
- Relationship
- Self
- Race
- Black or African American
- Ethnicity
- N/A
Registered dependents
MFH-89298-43319
Child or adolescent in my care · Female · 2021-11-11
HLT-32677-19867
Child or adolescent in my care · Male · 2021-11-11
Timeline
-
2021-02-24
Dose 1 — Moderna
-
2021-03-10
Registered in v-safe
- 2021-03-10
- 2021-03-17
- 2021-03-24
-
2021-03-26
Dose 2 — Moderna
-
2021-03-26
Health check-in — day 0, dose 2Feeling: Good · Site: Pain, Swelling · Muscle or body achesAdult check-in
-
2021-03-27
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain, Redness, Swelling · Headache, Joint pains, Muscle or body aches, Abdominal painAdult check-in
-
2021-03-28
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Pain · Muscle or body achesAdult check-in
-
2021-03-29
Health check-in — days 1–6 daily, dose 2Feeling: Good · Site: Itching · Muscle or body achesAdult check-in
- 2021-03-30
- 2021-03-31
- 2021-04-01
- 2021-04-02
- 2021-04-09
- 2021-04-16
- 2021-04-23
- 2021-04-30
- 2021-05-07
- 2021-06-26
- 2021-09-24
-
2021-11-05
Dose 3 — Moderna
- 2021-11-11
- 2021-11-12
- 2021-11-19
-
2021-11-26
Survey response — day 21, dose 3MedDRA: Secretion discharge — Feeling: FairFree text: Increased mucus productionMedDRA releases: 2024-11 · check-in free text available
-
2021-12-03
Survey response — day 28, dose 3MedDRA: Nasal dryness — Feeling: FairFree text: Dry noseMedDRA releases: 2024-11 · check-in free text available
- 2021-12-10
- 2021-12-17
- 2022-02-04
- 2022-05-08
- 2022-11-05
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-02-24 | Moderna | |
| 2 | 2021-03-26 | Moderna | |
| 3 | 2021-11-05 | Moderna | No |
Free text
Release 10 — day 21, dose 3
Symptoms: Increased mucus production
Release 10 — day 28, dose 3
Symptoms: Dry nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal dryness | · | · | ✓ |
| SD | Secretion discharge | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release